About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Prostate Cancer Drug Reduces Testosterone Levels Within 3 Days

by Hannah Punitha on December 5, 2008 at 1:07 PM
Font : A-A+

 Prostate Cancer Drug Reduces Testosterone Levels Within 3 Days

A prostate cancer drug, called degarelix, brought down testosterone levels within 3 days of administration in over 95 per cent of men, a new study has shown.

Those who took degarelix were also found to experience much greater falls in their prostate-specific antigen (PSA) levels at 14 and 28 days than men taking leuprolide.

Advertisement

For the study, the researchers from Canada, the USA, France, Denmark and the Netherlands studied 610 men as part of the Phase Three trial, randomly assigning them to one of three study groups.

"Androgen deprivation hormone therapy is an effective response to prostate cancer, but the drugs that are most widely used cause an initial rise in testosterone - the hormone we are trying to reduce - when the patient first takes them" explained lead author Dr Laurence Klotz from the Division of Urology at the University of Toronto, Canada.
Advertisement

He added: "We prefer to avoid this biochemical surge as it can stimulate the prostate cancer cells and exacerbate a number of clinical symptoms, such as spinal cord compression and bone pain. It could also result in more rapid growth of microscopic disease that is present in the patient but is too small to be detected.

"Degarelix is a new gonadotrophin-releasing hormone (GnRH) antagonist. It works by binding to, and blocking, the GnRH receptors in the pituitary gland, reducing the amount of LH and FSH hormones that are released. This leads directly to a rapid fall in testosterone."

Klotz said: "More than 2,000 patients have now taken part in clinical trials for degarelix and there have been no signs of immediate or late-onset systemic allergic reactions, in contrast to other reported trials of other GnRH antagonists.

"The aim of the study was to show that degarelix was not inferior to leuprolide when it came to maintaining low testosterone levels over a one-year treatment period. We have conclusively shown that this is the case.

"However, we have also demonstrated that degarelix - which is an antagonist - offers an advantage, in that it reduces testosterone and PSA levels very quickly. It doesn't cause the initial surge of testosterone seen with agonist drugs like leuprolide - the other drug featured in this study.

"This is relevant as biochemical surges in testosterone can stimulate the prostate cancer cells and cause unpleasant side effects for patients. They may also require further drug therapy to counteract the effects of agonist drugs like leuprolide."

The study was published in the December issue of BJU International.

Source: ANI
SPH
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Signature Drug Toxicity Prostate Cancer Facts Cancer Facts Andropause / Male Menopause Cancer Adreno Cortical Carcinoma 

Recommended Reading
Prostate Biopsy
Encyclopedia section of medindia gives general information about prostate gland...
Advantages of Eating Fish Foods
Researchers worldwide have discovered that eating fish regularly is good for health. Regular ......
Prostate Enlargement due to Benign Hyperplasia of Prostate or BPH - Animation
Are you troubled by urinary symptoms of prostate enlargement - View this medindia animation to ......
Adreno Cortical Carcinoma
Adrenocortical carcinoma is a rare but aggressive form of cancer that affects the outer cortex laye...
Andropause / Male Menopause
Andropause or male menopause causing low libido in a man is due to decreasing level of male hormones...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use